Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Latest News

Date posted: 1/15/2013

January 15, 2013 – Here in the United States, Bayer faces more than 12,500 lawsuits alleging that its popular birth control drugs Yaz and Yasmin caused blood clots.  They recently began settling many of the claims to avoid litigation.

In Europe, however, recent news shows patients are just starting to file Yaz lawsuits and are being joined by a powerful ally: insurance companies who want to recoup hundreds of thousands of dollars in hospitalizations costs.

Blood clots have been linked to dangerous conditions such as pulmonary embolism, deep vein thrombosis and stroke. In 2011, the British Medical Journal and FDA both warned that drugs like Yaz and Yasmin, which contain drospirenone, could increase blood clot risks by as much as 74%.

With the overwhelming popularity of the drugs, experts worry over the number of women who may have been affected. Already, due to the volume of cases filed, Yaz lawsuits have been consolidated to a special federal Multi-District Litigation court in Illinois.

In their most recent financial report, Bayer announced that they have set aside nearly $750 million so far to settle around 3,500 claims, at an average Yaz settlement of around $214,000 per case.* Bayer confirmed they are only settling claims involving blood clot injuries, such as deep vein thrombosis and pulmonary embolism.

Now, Reuters reports that CSS, Switzerland’s largest health insurer, has joined in a lawsuit filed by a young women who suffered pulmonary embolism after taking Yasmin. According to court filings, the insurer spent nearly $650,000 for several weeks of hospital treatment.**

Just weeks ago, France’s Health Ministry announced they would stop paying for late-generation oral contraceptives like Yaz and Yasmin after March due to concerns that the drugs increase blood clot risks.

Although Bayer is settling Yaz lawsuits in the United States, the time to file a claim could be limited.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

The Drug Risk Resource Center cautions victims that they should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

Contact us today for more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer.

*Bayer Interim Financial Statement, Legal Notes and Business Development, September 30, 2012

**Reuters: Swiss health insurer makes claim against Bayer over Yasmin pill,” January 9, 2013